Sq250 chen ling   600

Ling Chen

Corporate/Securities Attorney

Shanghai, China

About Ling Chen

Ling Chen is a corporate attorney at Sidley Austin LLP, a firm that provides legal services to fulfill the needs of their global clients. Chen is also the senior P.R.C. consultant for the firm’s Shanghai office. Additionally, she is experienced in several areas, including regulatory compliance, direct and indirect foreign investment in China, restructurings, mergers and acquisitions, private fund or hedge fund formation, and outbound investments. She also specializes in general commercial matters as well as corporate and regulatory matters.

Additionally, Chen is knowledgeable when it comes to assisting with dispute resolution matters before CIETAC and other issues related to dispute resolution. In the past, she completed her legal education with several leading law schools in the P.R.C. as well as Hong Kong. These schools include the Renmin University of China, where she received her Bachelor’s degree in Economics, and her L.L.M. degree from Peking University. Lastly, she received her M.C.L. degree from the University of Hong Kong.

Along with being fluent in Chinese and English, Chen has experience advising a wide range of clients. Recently, she has assisted clients with several extensive investment deals. These clients include but are not limited to the following: a world leader in the elevator industry, a major U.S. metal product company, a major U.S. hedge fund, numerous U.S. hedge funds, multiple foreign investors, a major U.S. private equity firm, a European private equity fund, and a U.S. private equity fund in obtaining a minority interest in a noteworthy project relating to the Olympic Games in the real estate sector.

Chen has also represented a U.S. Fortune 500 cosmetic company, and she helped them acquire substantial global and regional competitors. She has assisted a Fortune 500 U.S. food company in their efforts to acquire numerous Chinese companies. She has assisted a major U.S. drug company as well. Due to Chen’s efforts, they were able to obtain a human drug company currently operating in China.

Answers By Ling Chen

Ask a question 

Articles By Ling Chen